WHO WE ARE

Carocell Bio’s leadership team has extensive global experience in drug development and is committed to developing new medicines for patients with inflammatory diseases

Carocell Bio executive team

Dr Mike Davies MD, FRCRS, FRSPSG
CEO & Founder

Over 25 years’ global executive leadership experience in drug development in pharma (Pfizer, AstraZeneca, Shire) and biotech
Expertise in early-stage development and taking medicines from ideation to the market
Founder of Carocell Bio

John Nicholson
Chairman

International experience in the pharmaceutical and chemical industries
Funded and managed Analytical Services companies
Advisory Board member of the UK North West Business Fund
Previous Chairman Gentronix

Ann R. Mackey
Chief Financial Officer

Successful track record of leadership, launching operational initiatives, attracting talented managers, and developing effective teams.
Experienced with capital markets, corporate structuring, acquisitions, and venture capital.

Carocell Bio Advisory Team

Professor Fadi Issa
Consultant Burns and Plastic Surgeon

Buckinghamshire Healthcare NHS Trust Hospital & Health Care, Aylesbury , Buckinghamshire

Professor John Mclaughlin
Scientific Advisor, IBD

Professor of Gastroenterology and Nutrition, Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, UK

Professor Donald YM Leung
Scientific Advisor, AD

Professor and Head of the Division of Pediatric Allergy and Immunology, Department of Pediatrics at University of Colorado Denver School of Medicine, Denver, United States